Every round on record, with the sources behind each and the investors on them.
A digital pathology platform that uses AI to assess breast cancer risk
precisedx.aiLinkedInNew York, NYHealthtech
3 sources · checked 3 times, last 14h ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The filing-based item says there were nine investors but does not identify them or state a round stage.
3 sources
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source lists the round type as blank, so no stage is stated. It labels the valuation “undisclosed,” but does not state a valuation amount.; not on the page it cites, so not applied: valuation
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $3.7M | 2026-09-23 | not stated | No recent discussion |
3 sources · checked 3 times, last 14h ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 of 3 sources The filing-based item says there were nine investors but does not identify them or state a round stage. | ||||
PreciseDx builds an AI-powered digital pathology platform and breast-cancer test that analyzes pathology slides and clinical factors to help pathologists and oncologists assess recurrence risk and plan care for patients.
Checked against 10 sources today
| Funding round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $11M $43M to date | 2025-06-18 | Eventide Asset Management | No recent discussion |
3 sources [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 of 3 sources
The source lists the round type as blank, so no stage is stated. It labels the valuation “undisclosed,” but does not state a valuation amount.; not on the page it cites, so not applied: valuation [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]3 pages read: precisedx.ai, vcnewsdaily.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 of 3 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Series B | $20.7 million | 2024-08-21 | Eventide Asset Management | |